Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data Sources
1.4.1 Secondary
1.4.1.1 Paid sources
1.4.1.2 Public sources
1.4.2 Primary
Chapter 2 Executive Summary
2.1 Opioid use disorder (OUD) 3600 synopsis, 2018 – 2032
2.2 Drug type trends
2.3 Age group trends
2.4 Route of administration trends
2.5 Distribution channal trends
Chapter 3 Opioid Use Disorder (OUD) Market Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rise in drug approvals for the treatment of opioid use disorder
3.2.1.2 Increasing opioid addiction cases in developed counties
3.2.1.3 Increasing awareness for the adoption of buprenorphine patches as an effective treatment
3.2.2 Industry pitfalls & challenges
3.2.2.1 Adverse effects of OUD treatment drugs
3.3 Growth potential analysis
3.3.1 By drug type
3.3.2 By age group
3.3.3 By route of administration
3.3.4 By distribution channal
3.4 COVID- 19 impact analysis
3.5 Rising opioid epidemic
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Market share analysis , 2022
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Opioid Use Disorder (OUD) Market Size and Forecast, By Drug Type (USD Million)
5.1 Key trends, by drug type
5.2 Buprenorphine
5.2.1 Buprenorphine alone drugs
5.2.1.1 Sublocade
5.2.1.2 Belbuca
5.2.1.3 Other buprenorphine brands
5.2.2 Buprenorphine combined with naloxone drugs
5.2.2.1 Zubsolv
5.2.2.2 Suboxone
5.2.2.3 Bunavail
5.2.2.4 Other combinational drug brands
5.3 Naltrexone
5.4 Methadone
Chapter 6 Opioid Use Disorder (OUD) Market Size and Forecast, By Age Group (USD Million)
6.1 Key trends, by age group
6.2 19 to 40
6.3 41 to 60
6.4 61and over
Chapter 7 Opioid Use Disorder (OUD) Market Size and Forecast, By Route of Administration (USD Million)
7.1 Key trends, by route of administration
7.2 Oral
7.3 Intravenous
Chapter 8 Opioid Use Disorder (OUD) Market Size and Forecast, By Distribution Channel (USD Million)
8.1 Key trends, by distribution channel
8.2 Hospital pharmacies
8.3 Retail pharmacies
8.4 Online phtamacies
Chapter 9 Opioid Use Disorder (OUD) Market Size and Forecast, By Region (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Alkermes, Inc.
10.2 Indivior PLC
10.3 BioDelivery Sciences International, Inc.
10.4 Orexo US, Inc.
10.5 Titan Pharmaceuticals, Inc.
10.6 Omeros Corporation
10.7 Camurus
10.8 Hikma Pharmaceuticals PLC
10.9 AstraZeneca plc
10.10 Viatris Inc
